On 2024-02-27, Vaxcyte, Inc. (PCVX) announced earnings per share of $-1.82 for the fiscal quarter ending 2023-12-31, missing the average analyst estimate of $-0.90.
The next expected annoucement date for quarterly earnings is 2024-05-13, with an average estimated earnings per share of $-1.11 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-02-27 | 2023-12-31 | $-0.90 | $-1.82 |
| 2023-11-06 | 2023-09-30 | $-0.79 | $-0.91 |
| 2023-08-08 | 2023-06-30 | $-0.67 | $-0.70 |
| 2023-05-08 | 2023-03-31 | $-0.80 | $-0.70 |
| 2023-02-27 | 2022-12-31 | $-0.84 | $-0.73 |
| 2022-11-07 | 2022-09-30 | $-0.80 | $-0.93 |
| 2022-08-08 | 2022-06-30 | $-0.69 | $-0.80 |
| 2022-05-09 | 2022-03-31 | $-0.56 | $-0.68 |
| 2022-02-28 | 2021-12-31 | $-0.46 | $-0.54 |
| 2021-11-10 | 2021-09-30 | $-0.47 | $-0.51 |
| 2021-08-11 | 2021-06-30 | $-0.46 | $-0.46 |
| 2021-05-11 | 2021-03-31 | $-0.41 | $-0.41 |
| 2021-03-29 | 2020-12-31 | $-0.48 | $-0.41 |
| 2020-11-12 | 2020-09-30 | $-0.42 | $-0.41 |
| 2020-08-12 | 2020-06-30 | $-0.66 | $-1.72 |